Apr 28, 2023 / 07:00AM GMT
Matts Johansen - Aker BioMarine ASA - CEO
Good morning, and welcome to the presentation of the first-quarter results for Aker BioMarine, wherein myself and CFO, Katrine Klaveness, will take you through the highlights and the financials from the quarter. At the end of the session, we will host a Q&A session and you can already now start sending in your questions to [email protected].
I'm really looking forward to present to you today good development across all segments in Aker BioMarine, resulting in $69 million in revenue for the quarter, up 22% compared to the same quarter last year. We delivered a fairly low EBITDA of $6 million and a negative net result of $17 million as expected, following high unit costs coming in from low production in the fourth quarter.
Harvesting year to date is on par with the very strong beginning of last year. And specially the ingredients segments are showing really strong sales with 46% growth in the Qrill or the animal health nutrition segment and 44% growth in the Superba segment. Brands are also delivering good results with 10% growth year over
Q1 2023 Aker Biomarine ASA Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers